MM Clinical Advances From IMS 2024
November 15, 2024
View
Meet Team Dial, Participating in Memory of Pastor Steven Dial Sr., MMRF 2024 Walk/Run: Atlanta Spirit of Hope Honoree
October 17, 2024
IMS 2024 Myeloma Oral Sessions Day 4
September 29, 2024
IMS 2024 Myeloma Oral Sessions Day 3
September 28, 2024
IMS 2024 Myeloma Oral Sessions Day 2
September 27, 2024
IMS 2024 Myeloma Oral Sessions Day 1
September 26, 2024
Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting
September 25, 2024
2024 Accelerator
September 12, 2024
Meet Susan Speer, the Spirit of Hope Honoree for the Inaugural MMRF Walk/Run: Houston
September 11, 2024
Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor
August 26, 2024
Multiple Myeloma Research Foundation (MMRF) Announces New Publication on CoMMpass Study in Nature Genetics Defining Distinct Subtypes of Multiple Myeloma and High-Risk Genetic Markers
August 19, 2024
Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF’s Myeloma Investment Fund; Advances Clinical Development of Lead Program, QXL138AM
August 6, 2024
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
Get Your Free Toolkit
